Search Login Register

megakaryocyte potentiating factor Summary

Description: controls rate & extent of cytoplasmic maturation during megakaryocyte development; RefSeq NM_018857 (mouse); NM_013404 (human); do not confuse with SMRP protein, human

Also Known As: CAK1 antigen, human; ERC protein, rat; MPF protein, mouse; MSLN protein, human; Megakaryocyte potentiating factor, human Show All >>

Networked: 431 relevant articles (15 outcomes, 103 trials/studies) for this Bio-Agent

Key Diseases for which megakaryocyte potentiating factor is Relevant

  1. Neoplasms (Cancer) : 8 outcomes 45 studies in 218 results
  2. Mesothelioma : 4 outcomes 27 studies in 198 results
  3. Ovarian Neoplasms (Ovarian Cancer) : 2 outcomes 11 studies in 75 results
  4. Pancreatic Neoplasms (Pancreatic Cancer) : 1 outcome 11 studies in 51 results
  5. Adenocarcinoma : 1 outcome 10 studies in 60 results
Show All >>

Drugs Related to megakaryocyte potentiating factor

  1. Immunotoxins (Immunotoxin)
  2. Antigens
  3. Biological Markers (Surrogate Marker)
  4. Small Interfering RNA (siRNA)
  5. Monoclonal Antibodies
  6. DNA Vaccines
  7. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
  8. gemcitabine
  9. megakaryocyte potentiating factor
  10. Asbestos
Show All >>

Therapies Related to megakaryocyte potentiating factor

  1. Immunotherapy
  2. Heterologous Transplantation (Xenotransplantation)
  3. Drug Therapy (Chemotherapy)
  4. Quantum Dots (Quantum Dot)
  5. Intravenous Infusions
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.